Trial NCT00089544

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02588
Secondary IDs: CDR0000365499 NCI-2012-02588 RTOG-0330 U10CA021661

Last trial update was posted on 2018-04-13

MeSH Interventions

Dacarbazine Doxorubicin Ifosfamide Imidazole Isophosphamide mustard Lenograstim Liposomal doxorubicin Thalidomide

MeSH Conditions

Sarcoma

Other Conditions

Recurrent Adult Soft Tissue Sarcoma Stage I Adult Soft Tissue Sarcoma AJCC v7 Stage II Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7

Stopping Reasons

N/A

Limitations And Caveats

This study closed early due to unacceptably high rate of thromboembolic events in Cohort A and due to low accrual in Cohort B. For this reason efficacy endpoints other than response to pre-operative therapy were not reported.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID